These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8604705)

  • 21. Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow.
    Chung YK; Chang KY; Park HS; Kim MH; Lee KM; Lim TS; Kim HW
    Hemodial Int; 2014 Apr; 18(2):551-5. PubMed ID: 24422855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extracorporeal renal replacement therapies in lithium intoxication].
    Giunta R; Di Mario F; Greco P; Di Motta T; Maccari C; Parenti E; Rossi GM; Morabito S; Pistolesi V; Regolisti G; Fiaccadori E
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of lithium toxicity.
    Waring WS
    Toxicol Rev; 2006; 25(4):221-30. PubMed ID: 17288494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis.
    Liangos O; Sakiewicz PG; Kanagasundaram NS; Hammel J; Pajouh M; Seifert T; Paganini EP
    Am J Kidney Dis; 2002 May; 39(5):1047-53. PubMed ID: 11979349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonaemia due to ornithine transcarbamylase deficiency.
    Chen CY; Chen YC; Fang JT; Huang CC
    Ren Fail; 2000 Nov; 22(6):823-36. PubMed ID: 11104170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy.
    Fortin MC; Amyot SL; Geadah D; Leblanc M
    Intensive Care Med; 1999 Jun; 25(6):594-8. PubMed ID: 10416911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous renal replacement therapy: does technique influence azotemic control?
    Morimatsu H; Uchino S; Bellomo R; Ronco C
    Ren Fail; 2002 Sep; 24(5):645-53. PubMed ID: 12380911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure.
    Leblanc M; Moreno L; Robinson OP; Tapolyai M; Paganini EP
    Am J Kidney Dis; 1995 Dec; 26(6):910-7. PubMed ID: 7503065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total collected dialysate lithium concentration after successful dialysis treatment in case of intoxication.
    Schmidt JJ; Lorenzen J; Chatzikyrkou C; Lichtinghagen R; Kielstein JT
    BMC Pharmacol Toxicol; 2014 Sep; 15():49. PubMed ID: 25193402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients.
    Caprioli R; Favilla G; Palmarini D; Comite C; Gemignani R; Rindi P; Cioni L
    ASAIO J; 1993; 39(3):M606-8. PubMed ID: 8268609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report.
    Bailey AR; Sathianathan VJ; Chiew AL; Paterson AD; Chan BS; Arora S
    Crit Care Resusc; 2011 Jun; 13(2):120-2. PubMed ID: 21627581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of high-efficiency and standard haemodialysis providing equal urea clearances by partial and total dialysate quantification.
    Mactier RA; Madi AM; Allam BF
    Nephrol Dial Transplant; 1997 Jun; 12(6):1182-6. PubMed ID: 9198048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium.
    Clendeninn NJ; Pond SM; Kaysen G; Barraza JJ; Farrell T; Becker CE
    J Toxicol Clin Toxicol; 1982 Jun; 19(4):341-52. PubMed ID: 7143521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arteriovenous hemodiafiltration in children.
    Zobel G; Ring E; Trop M; Stein JI
    Int J Pediatr Nephrol; 1986; 7(4):203-6. PubMed ID: 3818180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.